Privia Health (PRVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Zacks Öffnen unter Zacks
Privia Health (PRVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Privia Health (PRVA) reported $603.85 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 25.8%. EPS of $0.02 for the same period compares to $0.03 a year ago.

The reported revenue represents a surprise of +7.84% over the Zacks Consensus Estimate of $559.95 million. With the consensus EPS estimate being $0.08, the EPS surprise was -76.19%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Privia Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Practice Collections: $914.8 million compared to the $877.47 million average estimate based on four analysts. Care Margin: $128.7 million compared to the $121.29 million average estimate based on four analysts. Platform Contribution: $67 million versus the four-analyst average estimate of $60.57 million. Implemented Providers (as of end of period): 5,535 versus the three-analyst average estimate of 5,513. Value-Based Care Attributed Lives (as of end of period): 1.61 million compared to the 1.52 million average estimate based on three analysts.

View all Key Company Metrics for Privia Health here>>>

Shares of Privia Health have returned +5.6% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Privia Health Group, Inc. (PRVA): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research